BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Hepa Wash Awarded ZIM Grant


1/18/2011 12:32:54 PM

Munich, 17th January 2011 - Munich, 17th January 2011 - Hepa Wash receives a € 125.000 grant from the Federal Ministry of Economic Affairs. The grant is paid within the central innovation program for medium-sized enterprises (ZIM) and supports the development of a production line for the fluids needed for the Hepa Wash liver support device.

Up to now dialysis fluids are manufactured in huge tanks of 5,000 liters or greater and are then filled into 5-liter-bags. The Hepa Wash production line will work continuously and the filling will be done immediately so that bulky mixing tanks are not necessary anymore. "The costs of the production will decline significantly", says Dr. Bernhard Kreymann, CEO of Hepa Wash GmbH. "With the in-house-production of the fluids we will be independent of suppliers and therefore even more competitive.”

Also the patient will significantly benefit from the innovation: The electrolyte household of treated patient is quite variable. Optimally each liver patient should get a dialysate specially adjusted according to the clinical picture. "Our production line will be able to produce individually tailored dialysates." says Kreymann.

About Hepa Wash GmbH

Hepa Wash GmbH, which is located in the "Munich Technology Center" (MTZ), works since its foundation in 2005 on a new liver support therapy, to reduce the high mortality of critically ill patients with liver failure. Recent studies revealed that existing therapies can hardly achieve any positive effects on survival of liver patients. However, the Hepa Wash procedure has a significantly increased detoxication capacity and is therefore expected to improve the survival rate of affected patients for at least 30 percent. Two in-vitro- and preclinical studies already showed the imposing beneficial effects of the procedure. The clinical study at II. Medical Clinic in Hospital rechts der Isar started in October 2010. For this study a TUEV approved prototype of the device is used. In parallel to the pilot study the company finishes the device for the CE certification.

More Informationen Description of Hepa Wash technology. Information about ZIM.

Contact

Daniela Becker, Hepa Wash GmbH, Agnes-Pockels-Bogen 1, 80992 München, Tel.: +49 (89) 4111842-24, Mail: daniela.becker@hepawash.com, Internet: www.hepawash.com


Read at BioSpace.com

Hepa Wash
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->